Blog•Mar 10, 2026
Methylene Blue
Methylene Blue, a synthetic dye turned drug, is gaining attention as a potent nootropic that improves mitochondrial efficiency, acts as an antioxidant, and modulates neurotransmitter systems. Clinical and pre‑clinical studies show low‑dose supplementation enhances memory, mood, and offers neuroprotective benefits in models of Alzheimer’s, Parkinson’s, and depression. The compound works by donating electrons to the mitochondrial electron transport chain and inhibiting monoamine oxidase, thereby increasing ATP production and serotonin levels. Safe dosing ranges from 0.5 to 4 mg kg⁻¹, but higher amounts can cause serotonin syndrome and other side effects.
By Nootropics Expert — Blog
Blog•Mar 10, 2026
Scientists Successfully Freeze and Rewarm Mouse Brain Slices
Researchers at Friedrich‑Alexander‑Universität Erlangen‑Nürnberg successfully vitrified mouse brain slices and, in a limited trial, an entire mouse brain, preserving neuronal structure and function after rewarming. By using a high‑concentration cryoprotective agent cocktail, they avoided ice crystal formation, maintained synaptic architecture,...
By SENS Research Foundation – The SENSible Blog
Blog•Mar 10, 2026
The Hypoxia Response as an Example of the Way in Which Mild Stressors Slow Aging
Researchers have shown that mild, repeated stressors such as hypoxia can trigger cellular maintenance programs, notably autophagy, which delays senescence and extends organismal lifespan. Under low‑oxygen conditions, oxygen‑dependent histone demethylases are inhibited, leading to increased histone methylation and stabilized chromatin...
By Fight Aging!
Blog•Mar 10, 2026
A View of the Present State of the Comparative Biology of Aging
The article reviews the emerging field of comparative biogerontology, emphasizing that while the hallmarks of aging have been mapped in laboratory models, their relevance across the vast diversity of animal species remains unclear. It argues that integrating molecular insights from...
By Fight Aging!
Blog•Mar 10, 2026
#597: Behavioral Psychology in Diet & Health Counselling – David Creel, PhD, RD
David Creel, PhD, RD, a clinical psychologist and dietitian at the Cleveland Clinic, emphasizes that lasting weight‑loss hinges on behavioral psychology rather than isolated diet or exercise prescriptions. He outlines a framework that blends collaborative communication, self‑monitoring, skill‑building, and relapse‑prevention...
By Sigma Nutrition — Articles
Blog•Mar 9, 2026
Complement System Biomarkers Change with Age, and More So in Dementia Patients
A decade‑long study of 235 cognitively normal adults tracked plasma levels of 14 complement proteins every two years. Five factors—C4, C4b, Factor I, Factor D and Properdin—showed progressive deviations only in participants who later developed Alzheimer’s disease. These peripheral changes...
By Fight Aging!
Blog•Mar 6, 2026
Reviewing What Is Known of the Virome in Aging
Recent open‑access review maps the human virome’s role in aging, highlighting how gut and circulating viruses influence immunity, inflammation, and metabolism. Age‑related virome changes include expansion of bacteriophage families, reactivation of latent herpesviruses, and altered viral diversity, with centenarians displaying...
By Fight Aging!
Blog•Mar 6, 2026
FMO-2 Upregulation Is Common to Multiple Longevity Associated Mutations in Nematodes
Researchers have identified flavin‑containing monooxygenase‑2 (FMO‑2) as a shared downstream effector in several long‑lived mitochondrial mutants of Caenorhabditis elegans, including clk‑1, isp‑1 and nuo‑6. RNA interference or genetic loss of fmo‑2 shortens the extended lifespan of these mutants, confirming its...
By Fight Aging!
Blog•Mar 5, 2026
The CONTEXT Framework: Why the Best Health Interventions Fail Without Context
The CONTEXT Framework reframes health optimization by prioritizing the circumstances surrounding an intervention over the intervention itself. It breaks decision‑making into seven coordinates—Client, Objective, Now, Terrain, Execution, eXchanges, and Tracking—to ensure each supplement, protocol, or technology aligns with the user’s...
By Outliyr — High Performance Longevity
Blog•Mar 5, 2026
Menopause Hormone Therapy: The Myths, the Medicine, and the “Why Didn’t Anyone Tell Me?” Moment
The article debunks long‑standing myths about menopausal hormone therapy (MHT) by highlighting how the 2002 Women’s Health Initiative (WHI) trial was misapplied to all women. It explains that the WHI tested an older cohort using a specific estrogen‑progestin combo, leading...
By Dr. Gabrielle Lyon — Blog
Blog•Mar 4, 2026
Episode 144 | Trail Steepness Vs. Difficulty
The Backpacking Light podcast’s Episode 144 examines how trail steepness reshapes hiking difficulty, revealing that metabolic cost does not increase linearly with slope. It highlights that mild downhill grades (‑5 % to ‑10 %) are most energy‑efficient, while steep uphill (≥20 %) and downhill (≤‑25 %)...
By Backpacking Light (independent publication)
Blog•Mar 3, 2026
Acetyl-L-Carnitine (ALCAR)
Acetyl‑L‑Carnitine (ALCAR) is a bioavailable form of L‑carnitine that readily crosses the blood‑brain barrier, delivering energy‑boosting fatty acids to mitochondria and supporting acetylcholine synthesis. Clinical studies show ALCAR can improve memory, mood, and fatigue, and it performs comparably to antidepressants...
By Nootropics Expert — Blog
Blog•Mar 3, 2026
How to Get Perfect Skin: A No-BS Lifter’s Guide
A dermatologist explains that there is no such thing as a healthy tan, emphasizing that any UV exposure triggers skin damage that accumulates from childhood into later years. Daily use of broad‑spectrum SPF 50 sunscreen is sufficient for most office workers,...
By Menno Henselmans Articles
Blog•Mar 3, 2026
Why Weight Training With Full ROM Is NOT Enough for Mobility
Weight training performed through a full range of motion does not automatically provide comprehensive mobility. While heavy squats and deadlifts can improve certain joint angles, they often fall short on deep hip flexion, ankle dorsiflexion, and thoracic extension. Targeted mobility...
By The Bioneer
Blog•Mar 3, 2026
#596: Why Do Omega-3 Trials Show Mixed Results?
Omega‑3 supplementation trials produce mixed results due to differences in dose, population risk, and chosen endpoints. High‑dose EPA/DHA studies in secondary‑prevention cohorts with elevated triglycerides, such as REDUCE‑IT, show significant cardiovascular benefit, whereas lower‑dose primary‑prevention trials like VITAL and ASCEND...
By Sigma Nutrition — Articles